Login / Signup
Evaluation of a novel combination therapy, based on trifluridine/tipiracil and fruquintinib, against colorectal cancer.
Mamoru Nukatsuka
Akio Fujioka
Hideki Nagase
Gotaro Tanaka
Hiroaki Hayashi
Published in:
Chemotherapy (2023)
The combination of FTD/TPI and fruquintinib could be a promising treatment option for colorectal cancer.
Keyphrases
</>
combination therapy
metastatic colorectal cancer
replacement therapy